Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRA Antikörper

Der Maus Monoklonal Anti-HLA-DRA-Antikörper wurde für FACS und IF validiert. Er ist geeignet, HLA-DRA in Proben von Human und Affe zu detektieren.
Produktnummer ABIN6153490

Kurzübersicht für HLA-DRA Antikörper (ABIN6153490)

Target

Alle HLA-DRA Antikörper anzeigen
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reaktivität

  • 97
  • 16
  • 10
  • 9
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Human, Affe

Wirt

  • 62
  • 49
  • 4
  • 1
  • 1
Maus

Klonalität

  • 67
  • 50
Monoklonal

Konjugat

  • 59
  • 12
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Dieser HLA-DRA Antikörper ist unkonjugiert

Applikation

  • 55
  • 52
  • 40
  • 34
  • 19
  • 16
  • 13
  • 10
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Klon

IPO-10
  • Verwendungszweck

    Mouse Monoclonal anti-MHC-II (HLA-DRA) (IPO-10), Purified, BSA-free

    Produktmerkmale

    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50 % of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70 % of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Aufreinigung

    Purified

    Immunogen

    Spleen cells of a patient with hairy cell leukemia (Daudi cells)

    Isotyp

    IgG3 kappa
  • Applikationshinweise

    Immunofluorescence 0.5-1 μg/mL
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Optimal dilution for a specific application should be determined by user

    Kommentare

    Ramos, Daudi or HuT78 cells. Tonsil or lymph node

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS (no BSA, no azide)

    Konservierungsmittel

    Azide free
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Andere Bezeichnung

    MHC-II (HLA-DRA)

    Molekulargewicht

    36 kDa

    Gen-ID

    3122, 520048

    UniProt

    P01903

    Pathways

    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!